Sarepta Therapeutics
SRPT
#1692
Rank
โ‚น856.59 B
Marketcap
โ‚น8,828
Share price
-5.18%
Change (1 day)
-13.98%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚น313.98 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total assets are โ‚น313.98 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sarepta Therapeutics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚น271.77 B4.98%
2022-12-31โ‚น258.87 B10.48%
2021-12-31โ‚น234.30 B7.34%
2020-12-31โ‚น218.28 B67.93%
2019-12-31โ‚น129.98 B13.21%
2018-12-31โ‚น114.81 B37.48%
2017-12-31โ‚น83.51 B189.78%
2016-12-31โ‚น28.81 B58.4%
2015-12-31โ‚น18.19 B-2.7%
2014-12-31โ‚น18.69 B3.81%
2013-12-31โ‚น18.01 B60.49%
2012-12-31โ‚น11.22 B290.25%
2011-12-31โ‚น2.87 B39.6%
2010-12-31โ‚น2.06 B-26.03%
2009-12-31โ‚น2.78 B126.93%
2008-12-31โ‚น1.22 B-19.06%
2007-12-31โ‚น1.51 B-16.22%
2006-12-31โ‚น1.80 B-28.7%
2005-12-31โ‚น2.53 B105.52%
2004-12-31โ‚น1.23 B-42.46%
2003-12-31โ‚น2.14 B56.49%
2002-12-31โ‚น1.37 B-15.93%
2001-12-31โ‚น1.63 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚น4.755 T 1,414.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น149.36 B-52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น143.10 B-54.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น42.84 B-86.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น369.81 B 17.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น160.68 B-48.83%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น176.64 B-43.74%๐Ÿ‡บ๐Ÿ‡ธ USA